A Phase 2, Open-label, Multicenter, Exploratory Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007900/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to gain initial safety, tolerability, pharmacokinetic, and
efficacy information on SPD489 in preschool children 4-5 years old who are diagnosed with
ADHD. Generating such data will provide data on the use of SPD489 in the preschool ADHD
population.
提供机构：
Vivli
创建时间：
2022-06-14
